ERBB2 and breast cancer: Moreover, HER2 is a direct target of miR-489, overexpression of miR-489 suppresses breast cancer invasion by attenuating HER2-PTPN11-MAPK signaling, which in turn inhibits miR-489, producing a mutually inhibitory loop (249).